- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02537106
A Comparison of the Effect of 1.5 Versus 3% NaCl on Brain Relaxation and Microcirculation
September 28, 2019 updated by: Dostalova Vlasta, MD, PhD, University Hospital Hradec Kralove
A Comparison of the Effect of 1.5% Versus 3% NaCl on Brain Relaxation and Microcirculation During the Supratentorial Brain Tumor Surgery, and Natremia and Osmolarity in Postoperative Period
Hyperosmotic solutions of 1.5% and 3% NaCl are equally effective for brain relaxation and microcirculation during brain surgery.
The effect of 1.5% NaCl on postoperative natremia and natriuresis is less pronounced.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All the patients meeting the study criteria will be randomized into two groups.
After standardized induction to general anesthesia all patients will be given the infusion of hyperosmotic NaCl 5 ml/kg/BW during 30 min, group A 1.5% NaCl, group B 3% NaCl.
Corticosteroids will be administered as usually.
After dura opening the brain relaxation score will be assessed by surgeon (1 = completely relaxed, 2 = satisfactorily relaxed, 3 = firm brain, 4 = bulging brain), and the first measurement of the brain microcirculation provided by use of SDF probe in the area of the healthy brain, and of perifocal oedema.
Both sites of investigation will be marked for the second measurement, which will be done after the end of tumor resection.
Laboratory examinations: natremia preoperatively, natremia and osmolarity peroperatively 1 hour after NaCl infusion and at the end of surgery.
Concentration of natrium will be examined in CSF after dura opening.
Anesthesia management will be according to the standardised protocol, the patients will be awaken and extubated after the end of the procedure at the operating theatre.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hradec Kralove, Czechia, 50005
- University hospital Hradec Králové
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- peripheral supratentorial brain tumors or metastasis
- indication for osmotherapy
- ASA status I-III
Exclusion Criteria:
- reoperation
- osmotherapy prior to surgery
- preoperative natremia less than 135 mmol/l and more than 140 mmol/l
- GCS less than 14
- obstructive hydrocephalus
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1.5% NaCl
After standardized induction to general anesthesia group A patients will be given the infusion of hyperosmotic 1.5% NaCl 5 ml/kg/BW during 15 min.
|
After the infusion of 1.5% NaCl and dura opening the microcirculation and the brain relaxation score will be measured in the area of healthy brain and perifocal oedema sites.
Microcirculation measurement will be repeated at the same sites after tumor resection.
|
Experimental: 3% NaCl
After standardized induction to general anesthesia group B patients will be given the infusion of hyperosmotic 3% NaCl 5 ml/kg/BW during 15 min.
|
After the infusion of 3% NaCl and dura opening the microcirculation and the brain relaxation score will be measured in the area of healthy brain and perifocal oedema sites.
Microcirculation measurement will be repeated at the same sites after tumor resection.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in brain microcirculation
Time Frame: from dura opening till the end of tumor resection
|
measurement by SDF probe MicroVision
|
from dura opening till the end of tumor resection
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in natremia
Time Frame: 1 hour after hypertonic NaCl infusion
|
mmol/l
|
1 hour after hypertonic NaCl infusion
|
Changes in natremia
Time Frame: 5 min after the end of surgery
|
mmol/l
|
5 min after the end of surgery
|
Changes in osmolarity
Time Frame: 1 hour after hypertonic NaCl infusion
|
mosm/l
|
1 hour after hypertonic NaCl infusion
|
Changes in osmolarity
Time Frame: 5 min after the end of surgery
|
mosm/l
|
5 min after the end of surgery
|
Concentration of natrium in cerebrospinal fluid
Time Frame: after dura opening
|
mmol/l
|
after dura opening
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in diuresis
Time Frame: at the time of extubation
|
ml/hour
|
at the time of extubation
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Vlasta Dostalova, MD., University hospital Hradec Králové
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2015
Primary Completion (Actual)
March 1, 2019
Study Completion (Actual)
May 1, 2019
Study Registration Dates
First Submitted
August 27, 2015
First Submitted That Met QC Criteria
August 31, 2015
First Posted (Estimate)
September 1, 2015
Study Record Updates
Last Update Posted (Actual)
October 1, 2019
Last Update Submitted That Met QC Criteria
September 28, 2019
Last Verified
September 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201508-S23P
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Tumors
-
University of FloridaCompletedCentral Nervous System TumorsUnited States
-
Children's Hospital Los AngelesUnknownBrain and Central Nervous System TumorsUnited States, Canada, Australia, Switzerland, New Zealand
-
St. Jude Children's Research HospitalCompletedBrain Tumors | Central Nervous System TumorsUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedBrain Tumors | Central Nervous System TumorsUnited States, Australia, Canada
-
Emory UniversityNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
Duke UniversityNational Cancer Institute (NCI)CompletedBrain and Central Nervous System TumorsUnited States
-
M.D. Anderson Cancer CenterTerminatedBrain Tumors | Central Nervous System TumorsUnited States
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI)CompletedVNP40101M in Treating Young Patients With Recurrent, Progressive, or Refractory Primary Brain TumorsBrain and Central Nervous System TumorsUnited States
-
Children's Hospital Medical Center, CincinnatiTerminatedSolid Tumors | Brain TumorsUnited States
Clinical Trials on 1.5% NaCl
-
University of IowaCompleted
-
Beth Israel Deaconess Medical CenterWithdrawnPain, Postoperative | Postoperative Pain | Analgesia | Pain, Post Operative | Oxytocin
-
Alcresta Therapeutics, Inc.CompletedExocrine Pancreatic InsufficiencyUnited States
-
The Hospital for Sick ChildrenTerminated
-
Tel Aviv UniversityCompletedAnxiety | Stress Related Disorder
-
Société des Produits Nestlé (SPN)Nutrasource Pharmaceutical and Nutraceutical Services, Inc.; Bruyere Research...Terminated
-
Société des Produits Nestlé (SPN)Completed
-
University of Illinois at ChicagoRush University Medical Center; American Society for Parenteral and Enteral...CompletedSystemic Inflammatory Response Syndrome | Oxidative Stress | Acute Respiratory Distress Syndrome | Euthyroid Sick SyndromesUnited States
-
Tianjin Medical University General HospitalRecruiting
-
Milton S. Hershey Medical CenterIncyte CorporationRecruitingHidradenitis SuppurativaUnited States